Baird lowered the firm’s price target on Vor Bio (VOR) to $14 from $22 and keeps an Outperform rating on the shares. The firm said Vor announced 3Q24 financials and provided pipeline updates, which were generally in line with expectations ahead of key ASH data.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio